Shanghai Pulmonary Hospital, Shanghai, China
Clinical trials sponsored by Shanghai Pulmonary Hospital, Shanghai, China, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pain block could keep lung surgery patients comfortable for days Results expected Sep 2026 (estimated)
- New drug may help lenses breathe easier after lung surgery Results expected Sep 2026 (estimated)
- New combo therapy shows promise for rare chest cancer Results expected Sep 2026 (estimated)
- Zapping acupoints before surgery may ease shoulder pain Results expected Dec 2026 (estimated)
- Can pulmonary fibrosis patients pull hard enough for their inhalers? Results expected Dec 2026 (estimated)
-
New combo therapy shows promise for shrinking lung tumors before surgery
Disease control OngoingThis study tests whether combining the drug toripalimab with targeted radiation (SBRT) before surgery can shrink tumors in people with stage IIA to IIIB non-small cell lung cancer. About 40 adults aged 18-75 with operable cancer will receive this neoadjuvant therapy, with or with…
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New pill shrinks lung tumors before surgery in early trial
Disease control OngoingThis study tests a pill called sunvozertinib given before surgery to people with a certain type of lung cancer (stage II-IIIB non-small cell lung cancer with EGFR exon 20 insertion mutations). The goal is to see if the drug can shrink tumors and improve surgical outcomes. About 2…
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC